CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(6.76%)
USD 0.01
(6.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -19.93 Million USD | 48.52% |
| 2022 | -38.72 Million USD | -90.54% |
| 2021 | -20.32 Million USD | -69.28% |
| 2020 | -12 Million USD | 52.72% |
| 2019 | -25.39 Million USD | -75.19% |
| 2018 | -14.49 Million USD | -11812.16% |
| 2017 | 123.76 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 11.78 Thousand USD | 101.1% |
| 2024 Q1 | -1.06 Million USD | 12.82% |
| 2023 Q4 | -1.22 Million USD | 88.05% |
| 2023 FY | -19.93 Million USD | 48.52% |
| 2023 Q3 | -10.26 Million USD | -178.95% |
| 2023 Q2 | -3.68 Million USD | 22.72% |
| 2023 Q1 | -4.76 Million USD | 78.1% |
| 2022 FY | -38.72 Million USD | -90.54% |
| 2022 Q4 | -21.74 Million USD | -1.19% |
| 2022 Q3 | -21.48 Million USD | -831.03% |
| 2022 Q2 | 2.93 Million USD | 87.97% |
| 2022 Q1 | 1.56 Million USD | 50.91% |
| 2021 Q2 | -23.45 Million USD | -44.82% |
| 2021 FY | -20.32 Million USD | -69.28% |
| 2021 Q1 | -16.19 Million USD | -78.72% |
| 2021 Q4 | 1.03 Million USD | -94.34% |
| 2021 Q3 | 18.29 Million USD | 177.99% |
| 2020 Q4 | -9.06 Million USD | -992.75% |
| 2020 FY | -12 Million USD | 52.72% |
| 2020 Q1 | -2.38 Million USD | 90.7% |
| 2020 Q2 | 267.38 Thousand USD | 111.23% |
| 2020 Q3 | -829.41 Thousand USD | -410.2% |
| 2019 Q1 | 110.38 Thousand USD | 102.56% |
| 2019 Q4 | -25.59 Million USD | -117353.06% |
| 2019 Q3 | -21.79 Thousand USD | -101.2% |
| 2019 FY | -25.39 Million USD | -75.19% |
| 2019 Q2 | -10.83 Thousand USD | -109.81% |
| 2018 Q1 | 173.45 Thousand USD | 0.0% |
| 2018 Q3 | -1.53 Million USD | -826.82% |
| 2018 Q2 | 211.17 Thousand USD | 21.74% |
| 2018 FY | -14.49 Million USD | -11812.16% |
| 2018 Q4 | -4.31 Million USD | -180.88% |
| 2017 Q3 | 299.99 Thousand USD | 5567.79% |
| 2017 Q2 | 5293.00 USD | 0.0% |
| 2017 FY | 123.76 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -370.809% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | 18.336% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -24.41 Million USD | 18.336% |
| Leafly Holdings, Inc. | -9.49 Million USD | -109.887% |
| LifeMD, Inc. | -20.59 Million USD | 3.209% |
| LifeMD, Inc. | -20.59 Million USD | 3.209% |
| TRxADE HEALTH, Inc. | -17.84 Million USD | -11.722% |
| PetMed Express, Inc. | -7.46 Million USD | -167.083% |
| Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.769% |